Effects of HOXA9 Inhibitor DB818 on the Growth of Acute Myeloid Leukaemia Cells

YURI SONODA; MAI ITOH; SHUJI TOHDA

doi:10.21873/anticanres.14950

Research ArticleExperimental Studies

Effects of HOXA9 Inhibitor DB818 on the Growth of Acute Myeloid Leukaemia Cells

YURI SONODA, MAI ITOH and SHUJI TOHDA

Anticancer Research April 2021, 41 (4) 1841-1847; DOI: https://doi.org/10.21873/anticanres.14950

YURI SONODA

Department of Laboratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MAI ITOH

Department of Laboratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SHUJI TOHDA

Department of Laboratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: tohda.mlab@tmd.ac.jp

Article
Figures & Data
Info & Metrics
PDF

Article Information

vol. 41 no. 4 1841-1847

DOI

https://doi.org/10.21873/anticanres.14950

PubMed

33813389

Published By

International Institute of Anticancer Research

Print ISSN

0250-7005

Online ISSN

1791-7530

History

Received December 28, 2020
Revision received March 1, 2021
Accepted March 4, 2021
Published online April 3, 2021.

Author Information

YURI SONODA,
MAI ITOH and
SHUJI TOHDA ⇑

Department of Laboratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan

Correspondence to: Shuji Tohda, MD, Ph.D., Department of Laboratory Medicine, Tokyo Medical and Dental University, Yushima 1-5-45, Bunkyo-Ku, Tokyo 113-8519, Japan. Tel.: +81 358035334, Fax: +81 358035629, e-mail: tohda.mlab{at}tmd.ac.jp

View Full Text

Statistics from Altmetric.com

Cited By...

7 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

HOXA9 transcription factor is a double-edged sword: from development to cancer progression

U Sangeetha Shenoy, Divya Adiga, Faisal Alhedyan, Shama Prasada Kabekkodu, Raghu Radhakrishnan

Cancer and Metastasis Reviews 2024 43 2
Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9‐dependent AML

Mélanie Lambert, Samy Jambon, Mohamed A. Bouhlel, Sabine Depauw, Julie Vrevin, Samuel Blanck, Guillemette Marot, Martin Figeac, Claude Preudhomme, Bruno Quesnel, David W. Boykin, Marie‐Hélène David‐Cordonnier

HemaSphere 2024 8 5
17β-neriifolin from unripe fruits of Cerbera manghas suppressed cell proliferation via the inhibition of HOXA9-dependent transcription and the induction of apoptosis in the human AML cell line THP-1

Shohei Takase, Young Sook Yun, Fuki Moriya, Saaya Sekine, Satoshi Yotsumoto, Katsunori Miyake, Tadahiro Yahagi, Akihiro Ito, Hideshi Inoue

Journal of Natural Medicines 2023 77 1
Aberrant stem cell and developmental programs in pediatric leukemia

Rebecca E. Ling, Joe W. Cross, Anindita Roy

Frontiers in Cell and Developmental Biology 2024 12
Emerging role of MYB transcription factors in cancer drug resistance

Bernhard Biersack, Michael Höpfner

Cancer Drug Resistance 2024
A Genome Wide CRISPR Screen Reveals That HOXA9 Promotes Enzalutamide Resistance in Prostate Cancer

Michael V. Roes, Frederick A. Dick

Molecular and Cellular Biology 2024 44 12
Histone methylation and acetylation in cancer: mechanism, progression, and targets

Su Bu, Ting Ye, Hang Gao, Hang Song, Yongfu Zhu

Oncologie 2025 27 1

PreviousNext

In this issue

Anticancer Research

Vol. 41, Issue 4

April 2021

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Effects of HOXA9 Inhibitor DB818 on the Growth of Acute Myeloid Leukaemia Cells

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 4 + 8 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Effects of HOXA9 Inhibitor DB818 on the Growth of Acute Myeloid Leukaemia Cells

YURI SONODA, MAI ITOH, SHUJI TOHDA

Anticancer Research Apr 2021, 41 (4) 1841-1847; DOI: 10.21873/anticanres.14950

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Effects of HOXA9 Inhibitor DB818 on the Growth of Acute Myeloid Leukaemia Cells

YURI SONODA, MAI ITOH, SHUJI TOHDA

Anticancer Research Apr 2021, 41 (4) 1841-1847; DOI: 10.21873/anticanres.14950

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

A genome wide CRISPR screen reveals that HOXA9 promotes Enzalutamide resistance in prostate cancer
TYRO3 Knockdown Suppresses the Growth of Myeloid Leukaemia Cells

Google Scholar

Keywords

HOXA9
leukaemia
inhibitor
gene knockdown

Main menu

User menu

Search

Effects of HOXA9 Inhibitor DB818 on the Growth of Acute Myeloid Leukaemia Cells

Article Information

Author Information

Statistics from Altmetric.com

Cited By...

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords